Divi's Laboratories Limited
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as beta carotene, astaxanthin, lycopene, a… Read more
Divi's Laboratories Limited (DIVISLAB) - Total Liabilities
Latest total liabilities as of September 2025: ₹27.38 Billion INR
Based on the latest financial reports, Divi's Laboratories Limited (DIVISLAB) has total liabilities worth ₹27.38 Billion INR as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Divi's Laboratories Limited - Total Liabilities Trend (2005–2025)
This chart illustrates how Divi's Laboratories Limited's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Divi's Laboratories Limited Competitors by Total Liabilities
The table below lists competitors of Divi's Laboratories Limited ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Wayfair Inc
NYSE:W
|
USA | $5.88 Billion |
|
The Swatch Group AG
PINK:SWGAF
|
USA | $1.88 Billion |
|
Capcom Co. Ltd
PINK:CCOEF
|
USA | $40.66 Billion |
|
ACS Actividades de Construcción y Servicios S.A
PINK:ACSAF
|
USA | $36.88 Billion |
|
InCapta Inc
PINK:INCT
|
USA | $358.47K |
|
Cipla Limited
NSE:CIPLA
|
India | ₹71.39 Billion |
|
Inspur Electronic Info Industr
SHE:000977
|
China | CN¥87.92 Billion |
Liability Composition Analysis (2005–2025)
This chart breaks down Divi's Laboratories Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.70 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | 1.89 | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Divi's Laboratories Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Divi's Laboratories Limited (2005–2025)
The table below shows the annual total liabilities of Divi's Laboratories Limited from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-03-31 | ₹19.78 Billion | +4.16% |
| 2024-03-31 | ₹18.99 Billion | +13.58% |
| 2023-03-31 | ₹16.72 Billion | +1.55% |
| 2022-03-31 | ₹16.47 Billion | +11.29% |
| 2021-03-31 | ₹14.79 Billion | +20.70% |
| 2020-03-31 | ₹12.26 Billion | +13.38% |
| 2019-03-31 | ₹10.81 Billion | +25.56% |
| 2018-03-31 | ₹8.61 Billion | +7.48% |
| 2017-03-31 | ₹8.01 Billion | +31.59% |
| 2016-03-31 | ₹6.09 Billion | -33.08% |
| 2015-03-31 | ₹9.10 Billion | +21.77% |
| 2014-03-31 | ₹7.47 Billion | +17.08% |
| 2013-03-31 | ₹6.38 Billion | +2.08% |
| 2012-03-31 | ₹6.25 Billion | +30.97% |
| 2011-03-31 | ₹4.77 Billion | +39.95% |
| 2010-03-31 | ₹3.41 Billion | +11.14% |
| 2009-03-31 | ₹3.07 Billion | -3.30% |
| 2008-03-31 | ₹3.17 Billion | +2.98% |
| 2007-03-31 | ₹3.08 Billion | -0.34% |
| 2006-03-31 | ₹3.09 Billion | +81.19% |
| 2005-03-31 | ₹1.71 Billion | -- |